CFO
Catalyst Pharmaceuticals, Inc.
Board Member
Catalyst Pharmaceuticals, Inc.
Equibles does not estimate personal net worth.
Michael Kalb is recorded as Board Member at Catalyst Pharmaceuticals, Inc. since January 1, 2024 and CFO at Catalyst Pharmaceuticals, Inc.. Michael Kalb has spoken on 6 earnings calls across 1 company, most recently for Catalyst Pharmaceuticals, Inc. on February 26, 2026. Catalyst Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector.
“Good morning, everyone, and thank you for joining our conference call to discuss Catalyst's fourth quarter and full year 2025 financial results and business highlights.”
“Good morning, everyone, and thank you for joining our conference call to discuss Catalyst's Third quarter 2025 financial results and business highlights. Richard Daly, President and CEO, will lead the call today; and Jeffrey Del Carmen, our Chief Commercial Officer, and I will also present.”
“Good morning, everyone, and thank you for joining our conference call to discuss Catalyst's first quarter 2025 financial results and business highlights. Leading the call today is Richard Daly, Catalyst's President and Chief Executive Officer.”
“Good morning, everyone, and thank you for joining our conference call to discuss Catalyst Pharmaceuticals' third quarter 2024 financial results and business highlights.”
“Good morning, everyone, and thank you for joining our conference call to discuss Catalyst's second quarter 2024 financial results and business highlights. Richard Daly, President and CEO will be leading the call today, and Jeffrey Del Carmen, our Chief Commercial Officer, and I will also present.”
Catalyst Pharmaceuticals, Inc.
Board Member
Proxy statement
2024-01-01–present
Catalyst Pharmaceuticals, Inc.
CFO
Source not stated
Catalyst Pharmaceuticals, Inc.
Biotechnology · Healthcare
CFO, Board Member
2024-01-01–present
Catalyst Pharmaceuticals, Inc. Q4 FY2025 Earnings Call
Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. Q3 FY2025 Earnings Call
Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. Q1 FY2025 Earnings Call
Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. Q3 FY2024 Earnings Call
Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. Q2 FY2024 Earnings Call
Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. Q1 FY2024 Earnings Call
Catalyst Pharmaceuticals, Inc.
